COMMUNIQUÉS West-GlobeNewswire

PetVivo Holdings, Inc. Adds Dr. Tracy Turner, Creates Veterinary Advisory Board

13/06/2018 - 13:00

MINNEAPOLIS, June 13, 2018 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. ( www.petvivo.com ) (OTCMARKET:PETV), an emerging biomedical device company, is pleased to announce the addition of Dr. Tracy Turner of The Turner [...]

Late-Breaking Data and Clinician Reviews on Now FDA-cleared T2Bacteria Panel Underscore Sepsis Prevention Opportunities at ASM Microbe 2018

13/06/2018 - 13:00

LEXINGTON, Mass., June 13, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today late [...]

Avivagen Announces Distribution Agreement in Thailand

13/06/2018 - 12:30

OTTAWA, Ontario, June 13, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV)(“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion [...]

Wright Medical Group N.V. Announces FDA Premarket Approval for AUGMENT® Injectable Bone Graft

13/06/2018 - 12:00

Clinically Proven, Cost-Effective, Injectable Formulation of AUGMENT ® Approved in U.S. for Ankle and/or Hindfoot Fusion Company Can Now Initiate Commercial Sale and Distribution in the U.S. Company Plans to Update 2018 [...]

Japanese Medical Agency (PMDA) supports the expansion of the Phase III program for PledOx® to include Japanese patients

13/06/2018 - 08:30

Stockholm, June 13, 2018. PledPharma AB and Solasia Pharma K.K. (Solasia) today announced that the Japanese Pharmaceuticals and Medical Devices Agency, PMDA, following a meeting with PledPharma and Solasia, has [...]

Orion to join John Nurminen Foundation's Clean Baltic Sea projects as a new main partner

13/06/2018 - 08:01

Orion Corporation Press release 13 June 2018 at 9.00 a.m. Orion to join John Nurminen Foundation's Clean Baltic Sea projects as a new main partner Orion and the John Nurminen Foundation have signed an agreement on the [...]

Herantis Pharma announces initiation of Phase 2 study for Lymfactin® gene therapy in secondary lymphedema

13/06/2018 - 08:01

Herantis Pharma announces initiation of Phase 2 study for Lymfactin® gene therapy in secondary lymphedema Herantis Pharma Plc Company release 13 Jun 2018 at 9:00 am Herantis Pharma Plc ("Herantis") announced today the [...]

Shire plc : Rule 2.9 Announcement

13/06/2018 - 08:01

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 13 June 2018 Shire [...]

Novartis presents data to advance understanding of the role of IL-17A and reinforce Cosentyx® leadership in spondyloarthritis

13/06/2018 - 07:16

26 abstracts on Cosentyx ® (secukinumab) in ankylosing spondylitis (AS) and psoriatic arthritis (PsA) will be presented at the Annual European Congress of Rheumatology (EULAR 2018 )[1] Breadth of data covers updates on [...]

Sanofi : Sanofi successfully prices USD 2 billion bond issue

13/06/2018 - 07:01

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi successfully prices USD 2 billion bond issue Paris, France - June 13, 2018 - Sanofi has successfully priced its offering of USD 2 billion of notes [...]

Sanofi : Sanofi place un emprunt obligataire de 2 milliards de dollars

13/06/2018 - 07:01

Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi place un emprunt obligataire de 2 milliards de dollars Paris, France - Le 13 juin 2018 - Sanofi a placé avec succès une émission obligataire en 2 [...]

TiGenix announces a change in its Board of Directors and its Management Team

13/06/2018 - 07:01

PRESS RELEASE REGULATED INFORMATION INSIDE INFORMATION TiGenix announces a change in its Board of Directors and its Management Team Leuven (Belgium) - June 13, 2018, 07:00h CEST - TiGenix NV (Euronext Brussels and [...]

TiGenix annonce un changement dans son conseil d'administration et son équipe de direction

13/06/2018 - 07:01

COMMUNIQUÉ DE PRESSE INFORMATION RÈGLEMENTÈE INFORMATION PRIVILÉGIÉE TiGenix annonce un changement dans son conseil d'administration et son équipe de direction Louvain (Belgique) - 13 juin 2018, 7:00h CEST - TiGenix NV [...]

Bradmer Pharmaceuticals, Galaxy Digital and First Coin Announce Update and Results of Shareholder Meeting

13/06/2018 - 00:39

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES. TORONTO, June 12, 2018 (GLOBE NEWSWIRE) -- Bradmer Pharmaceuticals Inc. (“ Bradmer ” or the “ Company ”) (TSX-V:BMR.H), Galaxy [...]

Helix BioPharma Corp. Announces Fiscal Third Quarter 2018 Results

12/06/2018 - 23:16

RICHMOND HILL, Ontario, June 12, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX:HBP) (FRANKFURT:HBP) (“Helix” or the “Company”), a clinical stage immuno-oncology company developing innovative drug candidates for [...]

JDRF Canada applauds BC government’s decision to provide insulin pumps to people of all ages who live with type 1 diabetes

12/06/2018 - 22:41

TORONTO, Ontario, June 12, 2018 (GLOBE NEWSWIRE) -- JDRF Canada applauds the British Columbia government’s announcement today extending the province’s current insulin pump program to all ages. BC now joins Ontario, [...]

Vital Therapies Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

12/06/2018 - 22:30

SAN DIEGO, June 12, 2018 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, today reported a [...]

Assure Holdings Corp. Announces Update

12/06/2018 - 22:25

PARKER, Colo., June 12, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (TSXV:IOM) (OTCQB:ARHH) is providing an update relating to the appointment of its new auditor and an update relating [...]

ADMA Biologics Announces Closing of $40M Public Offering

12/06/2018 - 22:05

RAMSEY, N.J. and BOCA RATON, Fla., June 12, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq:ADMA) (“ADMA” or the “Company”) announced today the closing of its previously announced underwritten public offering of 8 [...]